A carregar...

Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study

BACKGROUND: This study was designed to evaluate the efficacy and safety of fulranumab, a fully human monoclonal antibody directed against nerve growth factor (NGF), for pain relief in patients with interstitial cystitis/bladder pain syndrome (IC/BPS). METHODS: In this multicenter, double-blind study...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Urol
Main Authors: Wang, Hao, Russell, Lucille J., Kelly, Kathleen M., Wang, Steven, Thipphawong, John
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217311/
https://ncbi.nlm.nih.gov/pubmed/28056917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-016-0193-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!